Press releases

1–15 of 16 items | Next »

PharMEDium Supports Draft Legislation, Efforts to Strengthen Oversight of the Compounding Industry
PharMEDium Supports Draft Legislation
PharMEDium Encourages Swift Action To Strengthen Federal Oversight of Advanced Sterile Compounding

PharMEDium Encourages Swift Action to Strengthen Federal Oversight

PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo: May 19-24, 2012 in Orlando, Florida
Visit Booth #2668 to see how the enhanced labels help clinicians and pharmacy staff with easier drug and dose recognition when stocking, retrieving, and administering compounded services from PharMEDium.
PharMEDium Announces Renewed Agreement with Healthtrust Purchasing Group

PharMEDium Announces Renewed Agreement with Healthtrust Purchasing Group to Deliver Outsourced Pharmacy Compounding Services

PharMEDium Announces the Extension of Its Agreement with Novation

PharMEDium Announces the Extension of Its Agreement with Novation to Deliver Outsourced Pharmacy Compounding Services

PharMEDium’s Technology Helps Hospital Pharmacists Ensure Safety

David N. Jonas, CEO, PharMEDium Services, announces the commitment to continue corporate R&D investments for innovations with an unprecedented focus on patient safety, quality and efficiency, providing hospital pharmacists with a steady stream of technologically-driven service advancements.

PharMEDium Unveils Drug Shortage and Usage Updates’ Enhancement on New Website with Focus on Patient Safety
Lake Forest, Illinois – August 15, 2011 — PharMEDium Services, LLC, market leader for customized pharmacy sterile compounding for hospital intravenous and epidural therapies, launched its new website, www.pharmedium.com, which now provides updates on drug shortages, patient safety and ready-to-use pharmacy compounding services.
PharMEDium Services, LLC Receives U.S. Patent 7,918,830. Entitled Safety Device for Drug Delivery Devices and Containers
PharMEDium Services, LLC announces that the United States Patent and Trademark Office has issued patent number 7,918,830 for a unique safety label for drug delivery containers...
PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
PharMEDium Healthcare Corporation has become an Industry Supporter of the American Society of Anesthesiologists (ASA), as a part of a new Corporate Supporter program...
PharMEDium Announces the Extension of Its Agreement with Novation to Deliver Outsourced Pharmacy Compounding Services
David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced the extension of its agreement with Novation to deliver outsourced pharmacy compounding services...
PharMEDium Announces Propofol
PharMEDium Services LLC, announced the addition of Propofol to its custom operating room anesthesia syringe preparation services...
PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development

David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation, announced that Thomas W. Rasnic has joined PharMEDium as Vice President, Quality, Regulatory Affairs and Research and Development.

PharMEDium Announces Enhanced Agreement with the Child Health Corporation of America (CHCA)
David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced an enhanced agreement with Child Health Corporation of America (CHCA), an Affiliate of Premier, Inc.
PharMEDium Elects William R. Spalding to Board of Directors
David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced the election of William R. Spalding to the company’s Board of Directors.
PharMEDium Awarded Premier Contract
PharMEDium Services, LLC, the leading national provider of pharmacy outsourced sterile I.V. compounding services, announced a new sole source agreement for admixture and compounding services – exclusive of total parenteral nutrition (TPN) compounding– with Premier Purchasing Partners, LP, the group purchasing unit of Premier, Inc.

1–15 of 16 items | Next »

Order from PharMEDium

Inquire online
Or call 1(800) 523-7749 for more information on sterile admixture services.

Dedication to Quality

PharMEDium utilizes FDA approved sterile drug components and containers to provide the highest quality preparations. PharMEDium conducts rigorous routine monitoring of its processes, facilities, personnel, admixtures, and compounding environment.

More about our quality »

Commitment to Innovation

We are committed to enhancing patient safety through innovation. Our research and development efforts provide customers with tomorrow’s technologically-driven service enhancements. Our strategic partnerships with drug and device manufacturers and clinical thought leaders work synergistically to enhance quality of care.

More about our innovation »

Count on Us

Dedicated 24/7 service and streamlined ordering provides you what you need when you need it.  For more than eighteen years, our clinical and technical experts have dedicated themselves to ensuring you have the tools and information to enhance the best care possible. Our critical back-up support systems and geographically diversified compounding centers can minimize supply disruptions.

More about our service »

PharMEDum Services, LLC Two Conway Park
150 North Field Drive, Suite 350
Lake Forest, Illinois 60045
Phone: (800) 523-7749 Fax: (847) 234-1363 customerservice@pharmedium.com

American Society of Anesthesiologists PharMEDium is a Corporate Supporter of the American Society of Anesthesiologists (ASA) and a